Literature DB >> 16107330

Histidine-rich glycoprotein specifically binds to necrotic cells via its amino-terminal domain and facilitates necrotic cell phagocytosis.

Allison L Jones1, Ivan K H Poon, Mark D Hulett, Christopher R Parish.   

Abstract

Cells that become necrotic or apoptotic through tissue damage or during normal cellular turnover are usually rapidly cleared from the circulation and tissues by phagocytic cells. A number of soluble proteins have been identified that facilitate the phagocytosis of apoptotic cells, but few proteins have been defined that selectively opsonize necrotic cells. Previous studies have shown that histidine-rich glycoprotein (HRG), an abundant (approximately 100 microg/ml) 75-kDa plasma glycoprotein, binds to cell surface heparan sulfate on viable cells and cross-links other ligands, such as plasminogen, to the cell surface. In this study we have demonstrated that HRG also binds very strongly, in a heparan sulfate-independent manner, to cytoplasmic ligand(s) exposed in necrotic cells. This interaction is mediated by the amino-terminal domain of HRG and results in enhanced phagocytosis of the necrotic cells by a monocytic cell line. In contrast, it was found that HRG binds poorly to and does not opsonize early stage apoptotic cells. Thus, HRG has the unique property of selectively recognizing necrotic cells and may play an important physiological role in vivo by facilitating the uptake and clearance of necrotic, but not apoptotic, cells by phagocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107330     DOI: 10.1074/jbc.M504384200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Molecular MRI of acute necrosis with a novel DNA-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium.

Authors:  Shuning Huang; Howard H Chen; Hushan Yuan; Guangping Dai; Daniel T Schuhle; Choukri Mekkaoui; Soeun Ngoy; Ronglih Liao; Peter Caravan; Lee Josephson; David E Sosnovik
Journal:  Circ Cardiovasc Imaging       Date:  2011-08-11       Impact factor: 7.792

Review 2.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

3.  Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity.

Authors:  Ali Rahnavard; Brendan Mann; Abhigya Giri; Ranojoy Chatterjee; Keith A Crandall
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

4.  Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival.

Authors:  Tor Persson Skare; Elin Sjöberg; Mattias Berglund; Ross O Smith; Francis P Roche; Cecilia Lindskog; Birgitta Sander; Ingrid Glimelius; Alex R Gholiha; Gunilla Enblad; Rose-Marie Amini; Lena Claesson-Welsh
Journal:  EJHaem       Date:  2020-08-06

Review 5.  Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 6.  Functional Regulation of the Plasma Protein Histidine-Rich Glycoprotein by Zn2+ in Settings of Tissue Injury.

Authors:  Kristin M Priebatsch; Marc Kvansakul; Ivan K H Poon; Mark D Hulett
Journal:  Biomolecules       Date:  2017-03-02

Review 7.  Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processes.

Authors:  Yixiao Pan; Lu Deng; Hai Wang; Kang He; Qiang Xia
Journal:  Genes Dis       Date:  2020-08-08

8.  Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells.

Authors:  Jonatan Leffler; Andrew P Herbert; Eva Norström; Christoph Q Schmidt; Paul N Barlow; Anna M Blom; Myriam Martin
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.